These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 27464768)

  • 1. Sleep Quality Is Related to Disease Activity in Patients With Ankylosing Spondylitis: A Polysomnographic Study.
    İn E; Turgut T; Gülkesen A; Yolbaş S; Akgöl G; Koca SS
    J Clin Rheumatol; 2016 Aug; 22(5):248-52. PubMed ID: 27464768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of sleep quality in patients with ankylosing spondylitis and efficacy of anti-TNF-α therapy on sleep problems: A polisomnographic study.
    Karatas G; Bal A; Yuceege M; Firat H; Gurcay E; Ardic S; Cakci FA
    Int J Rheum Dis; 2018 Jun; 21(6):1263-1269. PubMed ID: 28556500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of anti-TNF treatment on sleep problems in ankylosing spondylitis.
    Karadağ O; Nakas D; Kalyoncu U; Akdoğan A; Kiraz S; Ertenli I
    Rheumatol Int; 2012 Jul; 32(7):1909-13. PubMed ID: 21448640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of global postural reeducation exercise and anti-TNF treatments on disease activity, function, fatigue, mobility, sleep quality and depression in patients with active Ankylosing spondylitis: A prospective follow-up study.
    Coksevim NH; Durmus D; Kuru O
    J Back Musculoskelet Rehabil; 2018; 31(6):1005-1012. PubMed ID: 30412478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The unmet need for anti-tumour necrosis factor (anti-TNF) therapy in ankylosing spondylitis.
    Barkham N; Kong KO; Tennant A; Fraser A; Hensor E; Keenan AM; Emery P
    Rheumatology (Oxford); 2005 Oct; 44(10):1277-81. PubMed ID: 16105913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An international study on starting tumour necrosis factor-blocking agents in ankylosing spondylitis.
    Pham T; Landewé R; van der Linden S; Dougados M; Sieper J; Braun J; Davis J; Rudwaleit M; Collantes E; Burgos-Vargas R; Edmonds J; Olivieri I; van der Horst-Bruinsma I; Mielants H; Stone M; Emery P; van der Heijde D
    Ann Rheum Dis; 2006 Dec; 65(12):1620-5. PubMed ID: 16464984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spondyloarthritis Research Consortium of Canada (SPARCC) enthesitis index in Turkish patients with ankylosing spondylitis: relationship with disease activity and quality of life.
    Zahiroglu Y; Ulus Y; Akyol Y; Tander B; Durmus D; Bilgici A; Kuru O
    Int J Rheum Dis; 2014 Feb; 17(2):173-80. PubMed ID: 24576273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ankylosing spondylitis disease activity score is related to NSAID use, especially in patients treated with TNF-α inhibitors.
    Carbo MJG; Spoorenberg A; Maas F; Brouwer E; Bos R; Bootsma H; van der Veer E; Wink F; Arends S
    PLoS One; 2018; 13(4):e0196281. PubMed ID: 29689112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restless legs syndrome is associated with poor sleep quality and quality of life in patients with ankylosing spondylitis: a questionnaire-based study.
    Demirci S; Demirci K; Doğru A; İnal EE; Koyuncuoğlu HR; Şahin M
    Acta Neurol Belg; 2016 Sep; 116(3):329-36. PubMed ID: 26563408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha.
    Gorman JD; Sack KE; Davis JC
    N Engl J Med; 2002 May; 346(18):1349-56. PubMed ID: 11986408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics and treatment responses of patients satisfying the BSR guidelines for anti-TNF in ankylosing spondylitis.
    Gadsby K; Deighton C
    Rheumatology (Oxford); 2007 Mar; 46(3):439-41. PubMed ID: 17255137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sleep quality and associated factors in ankylosing spondylitis: relationship with disease parameters, psychological status and quality of life.
    Batmaz İ; Sarıyıldız MA; Dilek B; Bez Y; Karakoç M; Çevik R
    Rheumatol Int; 2013 Apr; 33(4):1039-45. PubMed ID: 22940709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ankylosing spondylitis in Central and Eastern Europe. Cross-sectional study on treatment modalities, disease activity and quality of life].
    Ebner W; Palotai T; Codreanu C; Géher P; Pahor A; Pavelka K; Smolen J; Szechiński J; Zlnay M
    Z Rheumatol; 2008 Oct; 67(6):503-10. PubMed ID: 18712402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the nonsteroidal anti-inflammatory drug-sparing effect of etanercept in axial spondyloarthritis: results of the multicenter, randomized, double-blind, placebo-controlled SPARSE study.
    Dougados M; Wood E; Combe B; Schaeverbeke T; Miceli-Richard C; Berenbaum F; Koppiker N; Dubanchet A; Logeart I
    Arthritis Res Ther; 2014 Nov; 16(6):481. PubMed ID: 25428762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The evaluation of sleep quality and response to anti-tumor necrosis factor α therapy in rheumatoid arthritis patients.
    Karatas G; Bal A; Yuceege M; Yalcin E; Firat H; Dulgeroglu D; Karataş F; Sahin S; Cakci A; Ardic S
    Clin Rheumatol; 2017 Jan; 36(1):45-50. PubMed ID: 27567629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Working life and physical activity in ankylosing spondylitis pre and post anti-tumor necrosis factor-alpha therapy.
    Prince DS; McGuigan LE; McGirr EE
    Int J Rheum Dis; 2014 Feb; 17(2):165-72. PubMed ID: 24576272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the Bath Ankylosing Spondylitis Disease Activity Index and a modified version of the index in assessing disease activity in patients with ankylosing spondylitis without peripheral manifestations.
    Song IH; Rudwaleit M; Listing J; Sieper J
    Ann Rheum Dis; 2009 Nov; 68(11):1701-7. PubMed ID: 19029168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The epidemiology of ankylosing spondylitis and the commencement of anti-TNF therapy in daily rheumatology practice.
    Vander Cruyssen B; Ribbens C; Boonen A; Mielants H; de Vlam K; Lenaerts J; Steinfeld S; Van den Bosch F; Dewulf L; Vastesaeger N
    Ann Rheum Dis; 2007 Aug; 66(8):1072-7. PubMed ID: 17261531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement in patient-reported outcomes for patients with ankylosing spondylitis treated with etanercept 50 mg once-weekly and 25 mg twice-weekly.
    Braun J; McHugh N; Singh A; Wajdula JS; Sato R
    Rheumatology (Oxford); 2007 Jun; 46(6):999-1004. PubMed ID: 17389658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Sleep quality in patients with ankylosing spondylitis].
    Aydin E; Bayraktar K; Turan Y; Omurlu I; Tastaban E; Sendur OF
    Rev Bras Reumatol; 2015; 55(4):340-5. PubMed ID: 25772656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.